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Fever is an important and relatively common
presentation of infections in returning travellers. The
most common infections diagnosed in febrile returning
travellers are malaria, dengue, mononucleosis, rickettsial
infections and typhoid and paratyphoid, but many
remain undiagnosed (Table 1).1 These conditions are
reflected in an Australian study of hospital admissions
of febrile returning travellers, although they were
in different proportions.2 A significant proportion of
travellers may have infections that are also common
in nontravellers, which can be a source of confusion.
The initial evaluation of these travellers should focus on
infections that are life threatening, treatable, or pose a
risk to public health. If an infection is thought to be one
of those that pose a risk to public health, often listed as
a notifiable disease, then the general practitioner should
liaise with public health authorities immediately.
Assessment
History
A history of travel is the most important question, and
some patients will volunteer that they have travelled
recently, particularly due to promotional campaigns by
immigration authorities. An accurate history will assist in
developing an appropriate differential diagnosis and help
guide initial investigations. Ask about:
• specific presenting symptoms
• medical history (including medication/drug history)
• possible exposure to infectious diseases, and
• details of travel history. This is often easiest by way of
a travel checklist, which could be used for any returned
traveller (Table 2).
Vaccination is generally very effective against a wide range
of national schedule diseases and travel related diseases.
However, some vaccinations, such as typhoid vaccination,
are not 100% protective. Many travellers do not seek pre-
travel health advice and may not be current for routine
national schedule or relevant travel related vaccines, or
may be immigrants or travellers from overseas that may
not be immunised. The travel history will be important for
determining the approximate incubation period for the
presenting illness (Table 3). In many cases, this will help
to eliminate several potential infections and shorten the
potential differential diagnoses.
Physical examination
Physical findings in returning travellers can be nonspecific
and can mimic nontravel related diseases. Certain findings
can be helpful (Table 4). For example, a cyclic fever may
indicate malaria; a maculopapular rash may be seen in
several diseases such as dengue, rickettsial infections,
leptospirosis, or human immunodeficiency syndrome (HIV);
and an eschar, a painless ulcer with a blackened centre, may
indicate a rickettsial disease such as scrub typhus (Table 2).
investigations
Initial laboratory investigations may include:
e a full blood count with differential
e thick and thin blood malaria films (where indicated by
the travel history)
e liver function tests
e cultures of blood and stool
e urine analysis with urine culture, and
e serological tests for arboviral or rickettsial infections
(where indicated by the travel history).
Additional tests may be requested based on the history
and finding of physical examination. Eosinophilia
is associated with Katayama fever due to acute
schistosomiasis, however, it may be unrelated to the febrile
illness and be associated with a coexisting helminthic
infection.3 Finally, it may be useful for the laboratory to
store a tube of 'acute' serum for retrospective antibody
detection with a paired convalescent specimen.
Common tropica~ diseases
Malaria
Malaria is a global tropical parasitic disease with more
than 300 million cases and 3 million deaths each year.4 On
average, over 600 cases of imported malaria are notified in
Australia each year.5.6 Malaria in humans is normally caused
by one or more of four species, Plasmodium falciparum,
P vivax, P malariae and P ovale. Worldwide, malaria
due to P falciparum and P vivax account for most of the
recorded malaria. Malaria due to P falciparum accounted
for about one-third of recorded cases in Australia during
the period 1991-1997;7 however a recent study of 482
cases of imported malaria in Western Australia from 1990-
2001 indicated that the proportion of P falciparum cases
during 1996-2001 had increased to about 44%.8 In Australia,
fatalities are occasionally reported, predominantly from P
falciparum. 9 Of those admitted with malaria to a specialist
infectious disease hospital in Australia, only 56% had
reportedly been taking malaria chemoprophylaxis. 1O
Malaria is a common finding of hospital presentations of
febrile travellers in Australia.2 Malaria caused by Pfalciparum
generally presents within the first month or so of exposure,
Specific pathogen or cause reported
Malaria
Dengue
Mononucleosis (due to Epstein-Barr
virus or cytomegalovirus)
Rickettsial infection
Salmonella typhi or S. paratyphi
infection
No specific cause reported
Total
(n=3907)
as its incubation period is the shortest of the Plasmodium
species, although onset may be delayed by suppressive
antimalarial drugs. 1O In contrast, malaria caused by P vivax
may present many months or years after exposure. No
signs or symptoms are specific to malaria, although fever
is almost always present so a high index of suspicion is
required for any traveller returning from a malarial area.
Complicated malaria, such as HIV, is a great mimicker and
the diagnosis should be considered in anyone returning
from amalarious area, until proven otherwise.
Malaria is diagnosed by:
• detecting the parasite in a blood film, or
• detecting circulating malarial antigen.
Laboratories with experience in detecting malarial parasites
should be used. Initial blood films may be negative, and
repeat films should be taken every 6-12 hours for 36-
48 hours before malaria can be confidently excluded,11
especially during typical cyclic spikes of fever, if present.
Malaria due to P falciparum is particularly dangerous, as
untreated complicated falciparum malaria can be fatal within
24-48 hours of presentation, particularly in young children.
Patients with falciparum malaria require hospital admission
until the patient has recovered and complications have
been excluded. Complications may include renal failure,
respiratory distress, altered consciousness, seizures,
shock, or severe anaemia.
As patterns of resistance evolve, current guidelines for
treatment of malaria should be consulted. In Australia these
are given in Therapeutic guidelines: antibiotic. 12 Severe malaria,
particularly due to P falciparum, may require intravenous
treatment. If eradication treatment with primaquine
is considered, then glucose-6-phosphate dehydrogenase
(G6PD) deficiency should be tested for before the drug is
administered. Specialist advice should be sought if the patient
does not improve or relapsing disease becomes problematic.
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Dengue
Dengue is a flavivirus transmitted by the largely urban
dwelling Aedes aegypti species of mosquito. It is a major
global public health problem and is 'Increasingly common
in returning travellers. 1 There are four serotypes of the
dengue virus that affect humans. Unfortunately, exposure
and immunity to one serotype does not seem to confer
protection to other serotypes; in fact, subsequent infection
with another serotype can be more severe.3
Onset of disease can be rapid with an incubation period
as short as 4-7 days. Infection may range from subclinical
disease to influenza-like illness, including fever, headache,
and myalgia; often with lymphadenopathy, erythema and/or
a rash; or complicated by haemorrhagic diatheses or shock
syndromes which can be fatal.
Dengue is usually diagnosed clinically and diagnosis
depends on virus isolation in the laboratory from blood,
amplification of viral nucleic acid or serological results
(dengue IgM or IgG seroconversion).
Supportive treatment is all that can be offered and severe
cases, especially those with evidence of complications, need
to be managed in hospital. Spontaneous resolution is usual
in uncomplicated dengue.
Dengue has important public health implications. The
rapid spread of disease is possible in a receptive area such
as Queensland (Australia). Numerous outbreaks of dengue
in northern Queensland can be attributed to travellers
returning with the disease from the tropics, including
southeast Asia, where the disease is widely endemic. If
dengue is suspected clinically, public health authorities
should be informed, particularly in jurisdictions where the
disease is notifiable.
Enteric fever (typhoid and paratyphoid)
Enteric fever is caused by Salmonella typhi (typhoid);
however a similar syndrome is caused by S. paratyphi and
other salmonella species. Infection is the clinical syndrome
caused by S. typhi or 'paratyphi' salmonella species.
Transmission is usually faecal-oral in nature and the disease
is widespread, particularly in tropical areas.
Enteric fever has an incubation period of 3-60 days and
can present with a remittent fever pattern together with
headache. Gastrointestinal symptoms may be present,
possibly constipation early and diarrhoea later,3 although
this may vary in children.3,11 A history of recent typhoid
vaccination does not rule out a diagnosis of typhoid as the
vaccine is only about 70% protective against S. typhi. 13
Diagnosis depends on laboratory culture, as serological
testing is unreliable, particularly if typhoid vaccination
has been undertaken previously. Once malaria has
been excluded, empiric therapy for enteric fever may be
considered for those with prolonged fever. As patterns of
resistance evolve, current guidelines for the treatment of
typhoid should be consulted. 12
Complications may include gastrointestinal perforation,
haemorrhage, severe toxaemia, haemolytic anaemia, renal
disease, or typhoid abscess.
Rickettsial disease
Fever, headache and myalgia, while a nonspecific triad
of symptoms in returning travellers, may indicate one of
a number of rickettsial diseases3 including scrub typhus,
African tick bite fever and Mediterranean and Rocky
Mountain spotted fever. All of these rickettsial diseases are
transmitted by arthropod (mostly tick) bites, although a bite
may not be reported. Rickettsial diseases are widespread
• Where did you travel?
• When did you travel:
- departure date
- return date?
• Did you travel in:
- urban areas
- rural areas?
-What was the purpose of your travel:
- tourism
- visiting friends or relatives
- business
- other?
- What special activities did you undertake:
- mountaineering
- scuba diving
- caving
- other?
• Did you experience any specific risk exposures:
- sexual risks
- consume poor quality water or food
- ticks or other insect bites
- swim in lakes
- contact with wildlife?
• What vaccinations did you receive?
- Were you taking malaria prophylaxis?
If so:
- which drug did you take
- when did you start it
- did you take it regularly as directed
- are you still taking it?
- Did you become ill while away?
- Did anyone accompanying you become ill?
and are found in many parts of Australia. Rickettsial disease
should be suspected in patients with fever and a rash,
particularly if an eschar is present (Figure 1), who have
travelled, camped and/or hiked in an endemic area.
Serological testing is available, however, acute
serological testing is often negative. Empirical therapy
with doxycycline is often commenced while awaiting
results of tests on convalescent sera. Current guidelines
for treatment of rickettsial diseases should be consulted. 12
Complications of these diseases Complications of scrub
typhus include heartfailure and pneumonia.
Respiratory infections
About 20-40% of travellers have respiratory symptoms
while away or on return.1.2· 14 The most common causes
are allergy and viral infection of the upper respiratory
tract. 13 Influenza is also becoming an increasing
concern for returning travellers. 15 Less commonly,
respiratory symptoms may be present in travellers with
Legionnaire disease, histoplasmosis, coccidioidomycosis,
and Q fever.3,16 Transient migration of larval helminths
(eg. hookworms) should be considered in nonspecific
respiratory symptoms, particularly where there is evidence
of a cough, nonspecific pulmonary infiltrates and a
peripheral eosinophilia (Loftier syndrome).11,16
Emerging infectious diseases
Recent concerns regarding severe acute respiratory
syndrome and avian influenza and widespread influenza
pandemic planning has helped raise awareness of possible
emerging infectious diseases or other diseases of public
health importance. 19 The suite of viral haemorrhagic
Short
«10 days)
Malaria
Influenza
Arboviral infections including
dengue, yellow fever
Plague
Enteric bacterial infections
including paratyphoid fever
African tick bite fever
Spotted fever group (including
Rocky Mountain spotted fever)
Intermediate
(10-21 days)
Malaria
Viral haemorrhagic fevers
Typhoid fever
Scrub typhus
Q fever
Relapsing fever (Borrelia
spp.)
African trypanosomiasis
Brucellosis
Leptospi rosis
Long
(>21 days)
Malaria
Hepatitis A, B, C, E
Schistosomiasis (Katayama fever)
Leishmaniasis
Amoebic liver abscess
Tuberculosis
Filariasis
HIV
Physical finding
Rash
Jaundice
lymphadenopathy
Hepatomegaly
Splenomegaly
Eschar
Haemorrhage
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Infection or disease implicated
Dengue, typhoid, rickettsial infections, syphilis, gonorrhoea, Ebola virus,
brucellosis
Hepatitis, malaria, yellow fever, leptospirosis, relapsing fever
Rickettsial infections, brucellosis, dengue, HIV, lassa fever, visceral
leishmaniasis
Amoebiasis, malaria, typhoid, hepatitis, leptospirosis
Malaria, relapsing fever, trypanosomiasis, typhoid, brucellosis, kala-azar, typhus,
dengue
Rickettsial infections, borrelia, Crimean-Congo haemorrhagic fever
Dengue, meningococcaemia, Lassa fever, Marburg or Ebola viruses, Crimean-
Congo haemorrhagic fever, Rift Valley fever, yellow fever, epidemic louse borne
typhus, Rocky Mountain spotted fever
diseases, such as Lassa fever and Ebola virus, although
rare in travellers, presents an ever present concernY
Several treatable infections and viral infections (eg. dengue)
of travellers can cause fever associated with haemorrhage
in traveliersY However, because of the public health
implications, viral hemorrhagic fevers need to be considered
in travellers who present with fever and haemorrhage
returning from endemic areas, and public health authorities
should be consulted.
Summary of important points
• Febrile illness is a common presenting feature
in returning travellers and requires a clinical and
epidemiological risk assessment.
• A complete history and examination together with
initial laboratory investigation may give a clue to the
diagnosis of a tropical disease; an estimate of the
incubation period may narrow the differential diagnosis.
• Fever in returning travellers requires urgent investigation
to exclude malaria and preventable deaths; persistence
may be required in the laboratory diagnosis of malaria.
• There is an increasing concern to consider emerging
infectious diseases and diseases of public health
importance.
Resources
• Cohen J. Traveller's pocket medical guide and international
certificate of vaccination. Available at: www.travelclinic.com.
au/pocket-guide.asp
• Leggat PA, Goldsmid JM, editors. Primer of travel medicine. 3rd
revised edn. Available at: www.tropmed.org
• Mills D. Travelling well. Available at: www.travellingwell.com.au
• Steffen R, DuPont HL, Wilder-Smith A. Manual of travel medicine
and health. 3rd edn. Hamilton, Canada: BC Decker, 2003
• Yung A, Ruff T, Torresi J, Leder K, O'Brien D. Manual of travel
medicine. 2nd edn. Melbourne: IP Communications, 2004
• Centres for Disease Control and Prevention. Health information
for international travel. Available at: www.cdc.gov/travel
• Travel Health Advisory Group, Australia. Available at: www.well-
togo.com.au
• World Health Organisation. International travel and health.
Available at: www.who.int/ith.
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